NASCAR Doubleheader is about racing, philanthropic endeavors poconorecord.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from poconorecord.com Daily Mail and Mail on Sunday newspapers.
LVHN-Pocono gets COVID-19 vaccine, Moderna s arrives in Wilkes-Barre
COVID-19 vaccinations continue to spread across the commonwealth and into the Poconos as the effort to combat the coronavirus via inoculations gains momentum.
Lehigh Valley Health Network-Pocono received its first shipment of the highly-anticipated Pfizer-BioNTech coronavirus vaccine on Friday, Dec. 18, and physicians immediately began doling it out to staff members that very day.
Director of Cardiopulmonary Services Francine Rich-Benton was the first to receive her shot, after which she signed the hospital network’s “Doing My Part” poster to show her commitment to fighting the pandemic.
“It was so exciting to be a part of something so big, that we need so desperately,” Rich-Benton said. “It’s a great feeling to motivate family and friends and the community. I wanted to show them this is important, and don’t wait.”
Pocono, Schuylkill campuses get vaccine – Times News Online tnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tnonline.com Daily Mail and Mail on Sunday newspapers.
Hospital networks and health care systems across northeastern Pennsylvania began doling out doses of the COVID-19 vaccine to staff this week, kicking off the first phase of an effort to curb the coronavirus pandemic in the commonwealth.
Regional distribution of the Pfizer-BioNTech COVID-19 vaccine, which received emergency use authorization from the Food and Drug Administration on Dec. 11, began with high-risk individuals in the health care field, along with residents of long term care facilities, as per the recommendations of the Centers for Disease Control’s Advisory Committee on Immunization Practices and the Pennsylvania Department of Health.
The vaccine, which has an efficacy rating of 95%, consists of two doses spaced three weeks apart.